RE: Observations7 Mar 2024 19:20
I was merely giving my personal view, based on my own experience of AIM and of He1. We have to be realistic here. AIM is a volatile market even at the best of times, and the junior explorers in particular. The share price is unlikely to be able to go on a SUSTAINED rise in the following circumstances:
1) there is no confirmed commercial discovery and questions remain about it.
2) these questions are not going to be unequivocally and definitively answered now until the EWT and/or the appraisal drilling.
3) the first of these events is not taking place until Q3.
4) it is highly unlikely that He1 will attract offtake funding or JV during this hiatus period.
5) but it is highly likely that He1 will need to do a raise during this period.
I just don't see how the AIM punters are going to do what they never usually do in high numbers, which is have their money bleeding down in this share for up to 4 months before the next significant milestone event is prepared, especially with all the anguish and opportunity cost that entails. And not when there's a placing happening beforehand.
As Trek put it, there's a time to be in these companies (operations) and a time to be out (when they need money for operations).
So I'm expecting a sell down (as is the AIM usual response in these situations), then a period of funding uncertainty for the Q3 EWT. Once funding is resolved, that is when I suspect the herd will be back.
Maybe NHE might be the better bet in the short term, because they will be moving to appraisal stage very shortly? In fact, their appraisal results could effect the He1 share price (positively or negatively) as well during this 'hiatus' period, so I would also factor it into my analysis.
I could be wrong of course, and never trade or invest based on my personal opinion. Price action is always king, so I will keep a watchful eye on the share price, but unless it tells me differently, I don't anticipate having large funds tied up here waiting for Q3. But each to their own. All imo, dyor and GLA